Two-year results of cataract extraction with implantation of the hydrophilic acrylic B-lens.

PURPOSE: To evaluate the safety and efficacy of a hydrophilic acrylic intraocular lens (B-Lens((R)), Hanita, Israel) during a 2-year follow-up period. SETTING: Department of Ophthalmology, Meir Hospital, Sapir Medical Center, Kfar-Saba, Israel. PATIENTS & METHODS: Slit lamp biomicroscopy, refraction, visual function and patient satisfaction were recorded in 147 patients at 1 week, and at 1, 3, 12, and 24 months after surgery. RESULTS: Nine cases (6%) were associated with partial rupture of the superior haptic intraoperatively, which did not preclude in-the-bag centration of the IOL in all cases. Postoperative complications were mild or reversible and rarely observed. The posterior capsule opacification (PCO) rate increased considerably (from 0.35 to 0.80) from 1 to 2 years but was for the most clinically insignificant; 16 of the 90 cases (18%) with PCO at 2 years had clinically significant opacification of the posterior capsule. No IOL discoloration was observed. BCVA stabilized by the third month and refraction was at the predicted level at two years. Eighty-one of 91 cases (89%) had BCVA equal to or more than 20/40 and 43 of 91 (47%) gained a BCVA of 20/20 at two years. CONCLUSION: Hydrophilic acrylic B-Lens((R)) implantation is safe and effective for patients with cataract.

Treatment of idiopathic orbital inflammatory disease with cyclosporine-A: a case presentation.

We present a case of idiopathic orbital inflammatory disease that was responded favorably to low-dose cyclosporine-A.

Long-term results of Ahmed glaucoma valve implantation for uveitic glaucoma.

PURPOSE: To present long-term outcomes of Ahmed glaucoma valve implantation for uveitic glaucoma. DESIGN: Interventional case series. METHODS: Retrospective chart review of 60 patients (60 eyes) with uveitic glaucoma who underwent Ahmed valve implantation over a four-year period at a tertiary uveitis referral center. Success definition 1 included patients with an intraocular pressure (IOP) between 5 and 21 mm Hg, reduced by 25% from that before implantation. Success definition 2 (qualified success) excluded those patients in whom serious complications occurred. RESULTS: Mean follow-up time was 30 months (range, six to 87 months; four-year results relate to a cohort of 15 patients). Success rates were 77% and 50% and qualified success rates were 57% and 39% at one and four years, respectively. At four years, 74% of the patients required glaucoma medication to maintain IOP control. The overall complication rate was 12%/person-years. The rate of visual acuity loss was 4%/person-years; that was most commonly attributed to corneal complications that were more likely to occur in patients with preoperative corneal disease (P = .01, Fisher exact test). CONCLUSIONS: Ahmed glaucoma valve implantation is a safe yet moderately successful procedure for uveitic glaucoma. Long-term success rates are enhanced with the use of glaucoma medications, and corneal complications are the most common of all potential serious complications.

Human amniotic membrane transplantation for tube exposure after glaucoma drainage device implantation.

We present a case of conjunctival melting over the tube of a glaucoma shunt, which was successfully repaired with amniotic membrane transplantation.

Conjunctival non-caseating granulomas in a human immunodeficiency virus (HIV) positive patient attributed to sarcoidosis.

PURPOSE: To report a rare case of isolated ocular sarcoidosis in an HIV positive patient. DESIGN: Case report. METHODS: A 47-year-old HIV+ Caucasian male was referred for chronic bilateral follicular conjunctivitis. RESULTS: A conjunctival biopsy that was performed on the right eye showed sarcoidosis. General medical evaluation including a spiral thin cut chest CT scan revealed no systemic involvement. The ocular signs and symptoms resolved completely with topical corticosteroid treatment. CONCLUSIONS: HIV infection and sarcoidosis rarely coexist, presumably because their immunopathogenesis mechanisms diverge. In the absence of systemic involvement, a definite diagnosis can only be made by biopsy of the ocular tissues.